Understanding peptide research evidence
A compound being studied is not the same as a treatment being proven. The study model, methods and limitations matter as much as the headline result.
By Manchester Peptides · ·
Preclinical findings are a starting point
Preclinical research includes laboratory and living-organism studies before testing in people. The FDA describes this stage as a way to investigate potential toxicity and decide whether further testing in humans is appropriate. A promising preclinical finding does not itself establish a clinical benefit.
Five questions to ask about a claim
- Was the work conducted in a laboratory model, animals or people?
- What outcome did the researchers measure, and is that what the headline claims?
- How many participants or samples were included, and was there a comparison group?
- Are limitations, adverse findings and conflicts of interest discussed?
- Can the claim be traced to the full paper rather than a testimonial or an isolated screenshot?
Keep quality testing separate from clinical evidence
A report about a sample and a study about biological effects answer different questions. Neither should be used as a substitute for the other. Documentation of a research material does not establish that it is appropriate for personal use.
Source and further reading
FDA: Step 2—Preclinical Research explains this stage of the US drug-development process; it is not a statement of UK authorisation.
Related: reading a certificate of analysis →